Stocktoria

Tango Therapeutics, Inc. TNGX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-09-03

Tango Therapeutics, Inc. statistics & valuation

Market cap$5.1B
P / S82.1×
P / B14.8×
Net margin-162.9%
Return on equity-29.3%
FCF margin-224.3%
Return on capital-29.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-678.80% -157.20% -435.10% -278.50% -309.70% -162.90% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-681.80% -157.10% -446.80% -312.60% -346.10% -178.40% 202020212022202320242025
Return on equity (%)
-134.60% -16.90% -43.40% -40.20% -65.30% -29.30% 202020212022202320242025
Shares outstanding
40.4M 87.6M 88.2M 102.2M 109.2M 135.9M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-25.10% -11.60% -24.80% -25.30% -41.20% -25.50% 202020212022202320242025
Free cash flow margin (%)
900.80% -165.70% -469.70% -327.20% -314.40% -224.30% 202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$0.94 -$1.23 -$1.08 -$1.19 -$0.87 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-178.4%-346.1%-312.6%-446.8%-157.1%-681.8%
Net margin-162.9%-309.7%-278.5%-435.1%-157.2%-678.8%
FCF margin-224.3%-314.4%-327.2%-469.7%-165.7%900.8%
Return on assets-25.5%-41.2%-25.3%-24.8%-11.6%-25.1%
Return on equity-29.3%-65.3%-40.2%-43.4%-16.9%-134.6%
Current ratio16.326.987.546.7612.104.73

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.